UCMSCs‐derived exosomal circHIPK3 promotes ulcer wound angiogenesis of diabetes mellitus via miR‐20b‐5p/Nrf2/VEGFA axis

Abstract Aims Experiments confirmed that circular RNAs contributed to the pathogenesis of diabetic foot ulcers (DFUs). CircHIPK3 was upregulated in type 2 diabetes mellitus (T2DM), but its role in DFU remained unknown. Our study aimed to investigate the regulatory functions of exosomal circHIPK3 and its potential mechanisms in DFU. Methods Exosomal size and distribution, marker proteins, and circHIPK3 levels were evaluated by transmission electron microscope, ExoView R200, western blot, and qRT‐PCR. Flow cytometry, MTT, Wound healing assays, and tube formation assays were used to assess the roles of exosomal circHIPK3 in high glucose (HG)‐treated human umbilical vein endothelial cells (HUVECs). The relationships between Nrf2/VEGFA/circHIPK3 and miR‐20b‐5p, and between Nrf2 and VEGFA were determined by luciferase reporter assay and RNA immunoprecipitation. We used cell and mice models to investigate the mechanisms of exosomal circHIPK3 under diabetic conditions. Results CircHIPK3 was significantly upregulated in exo‐circHIPK3 rather than exo‐vector. Exo‐circHIPK3 remarkably inhibited cell apoptosis but promoted cell proliferation, migration, and tube formation in HG‐treated HUVECs. Luciferase reporter and RIP assays showed that miR‐20b‐5p targeted and inhibited Nrf2 and VEGFA, and circHIPK3 acted as a ceRNA of miR‐20b‐5p to inhibit the binding to its downstream genes Nrf2 and VEGFA. Mechanistically, circHIPK3 promoted cell proliferation, migration, and angiogenesis via downregulating miR‐20b‐5p to upregulate Nrf2 and VEGFA. However, the overexpressed miR‐20b‐5p could abolish the promoting effects of circHIPK3 overexpression on cell proliferation, migration, and tube formation under HG conditions. Conclusion UCMSCs‐derived exosomal circHIPK3 protected HG‐treated HUVECs via miR‐20b‐5p/Nrf2/VEGFA axis. The exosomal circHIPK3 might be a therapeutic candidate to treat DFU.